Home > Insider Trading > Filing (0001566028-13-000036)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
887497	Hi Tech Pharmacal Co Inc	HITK	Pharmaceutical Preparations (2834)	112638720

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1463267	M Gary April	C/O Hi-Tech Pharmacal Co., Inc. 369 Bayview Avenue Amityville NY 11701	President, Hcp Division	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-12-13	1,875	$19.59	1,875	No	4	M	Direct
Common Stock	Acquisiton	2013-12-13	1,874	$22.25	3,749	No	4	M	Direct
Common Stock	Acquisiton	2013-12-13	3,124	$31.93	6,873	No	4	M	Direct
Common Stock	Disposition	2013-12-13	6,873	$43.06	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2013-12-13	1,875	$0.00	1,875	$19.59
Common Stock	Stock Option (Right to Buy)	Disposition	2013-12-13	1,874	$0.00	1,874	$22.25
Common Stock	Stock Option (Right to Buy)	Disposition	2013-12-13	3,124	$0.00	3,124	$31.93

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2010-11-12	2019-11-12	No	4	M	Direct
1,876	2011-11-10	2020-11-10	No	4	M	Direct
9,376	2013-11-08	2022-11-08	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.05 to $43.07, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote [1] of this Form 4.
Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 2009 Stock Option Plan, which is a 16b-3 Plan.
Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 2012 Incentive Compensation Plan, which is a Rule 16b-3 Plan.
The options become exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date.
Other than the options to acquire 1,876 and 9,376 shares reflected on this form as still held by Mr. April following the reported transactions, Mr. April is also the holder of an additional option to acquire 9,375 shares of Hi-Tech common stock (for total options to acquire 19,845 shares still held by Mr. April), which option was granted in July 2012.